Sartorius Stedim Biotech S.A. (EPA:DIM)
France
· Delayed Price · Currency is EUR 204.40
-4.20 (-2.01%)
Feb 21, 2025, 5:35 PM CET
Sartorius Stedim Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 175.1 | 310.3 | 876.1 | 414.4 | 335.93 | Upgrade
|
| Depreciation & Amortization | 259.5 | 213.2 | 162.3 | 126.4 | 86.69 | Upgrade
|
| Other Amortization | 42.2 | 23.6 | 19.4 | 15.2 | 15 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.13 | Upgrade
|
| Loss (Gain) on Equity Investments | 8.6 | - | - | - | - | Upgrade
|
| Other Operating Activities | 78.7 | 8.6 | -94.2 | 291.6 | 22.73 | Upgrade
|
| Change in Accounts Receivable | 38.3 | 162.1 | -65.8 | -87.3 | -73.89 | Upgrade
|
| Change in Inventory | 207.6 | 131.2 | -217.9 | -275.4 | -116.62 | Upgrade
|
| Change in Other Net Operating Assets | 5.1 | -102.6 | -67.6 | 217 | 146.91 | Upgrade
|
| Operating Cash Flow | 815.1 | 746.4 | 612.3 | 701.9 | 416.88 | Upgrade
|
| Operating Cash Flow Growth | 9.20% | 21.90% | -12.77% | 68.37% | 34.42% | Upgrade
|
| Capital Expenditures | -339.8 | -473.6 | -430.6 | -324 | -159.19 | Upgrade
|
| Cash Acquisitions | - | -2,241 | -515.6 | -141.7 | -470.62 | Upgrade
|
| Investment in Securities | -0.1 | -8.1 | - | - | - | Upgrade
|
| Other Investing Activities | -0.1 | -0.1 | -11.3 | 0.5 | 8.69 | Upgrade
|
| Investing Cash Flow | -340 | -2,723 | -957.5 | -465.2 | -621.12 | Upgrade
|
| Long-Term Debt Issued | 17.3 | 2,649 | 566.8 | 74.2 | 334.79 | Upgrade
|
| Long-Term Debt Repaid | -879.2 | -326.4 | -174.4 | -79.7 | -35.32 | Upgrade
|
| Net Debt Issued (Repaid) | -861.9 | 2,323 | 392.4 | -5.5 | 299.47 | Upgrade
|
| Issuance of Common Stock | 1,194 | 1.3 | - | - | - | Upgrade
|
| Repurchase of Common Stock | -1.9 | - | -3.2 | - | - | Upgrade
|
| Common Dividends Paid | -67.1 | -132.7 | -116.1 | -62.7 | -31.34 | Upgrade
|
| Other Financing Activities | -177.8 | -205.3 | -52.4 | -9.5 | -34.06 | Upgrade
|
| Financing Cash Flow | 84.9 | 1,986 | 220.7 | -77.7 | 234.07 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.3 | -0.3 | 8 | 4.8 | 1.77 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | Upgrade
|
| Net Cash Flow | 562.3 | 9.5 | -116.5 | 163.8 | 31.6 | Upgrade
|
| Free Cash Flow | 475.3 | 272.8 | 181.7 | 377.9 | 257.69 | Upgrade
|
| Free Cash Flow Growth | 74.23% | 50.14% | -51.92% | 46.65% | 47.96% | Upgrade
|
| Free Cash Flow Margin | 17.10% | 9.83% | 5.20% | 13.09% | 13.49% | Upgrade
|
| Free Cash Flow Per Share | 4.91 | 2.96 | 1.97 | 4.10 | 2.80 | Upgrade
|
| Cash Interest Paid | 176.9 | 116.7 | 10.3 | 8.3 | 8.06 | Upgrade
|
| Cash Income Tax Paid | 133.5 | 135.8 | 221.2 | 166.6 | 113.98 | Upgrade
|
| Levered Free Cash Flow | 369.8 | 81.05 | 93.93 | 425.14 | 219.13 | Upgrade
|
| Unlevered Free Cash Flow | 462.3 | 153.18 | 105.3 | 431.51 | 223.2 | Upgrade
|
| Change in Net Working Capital | -252.9 | -96.6 | 304.8 | -37.89 | 34.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.